FDA tags Editas' thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic

Submitted by admin on May 15, 2022 - 11:19pm

Source:

Fierce Biotech

News Tags:

Editas Medicine

FDA

beta thalassemia

EDIT-301

Headline:

FDA tags Editas' thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic

snippet:

Editas Medicine has picked up more regulatory privileges for its ex vivo gene-edited medicine, securing FDA orphan-drug designation in beta thalassemia ahead of the start of a clinical trial in the indication.

Search form

You are here

FDA tags Editas' thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic

FDA tags Editas' thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic